Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
Forxiga approved in Japan for type-1 diabetes
-
Forxiga approved in Europe for type-1 diabetes
-
First sub-analyses from the DECLARE-TIMI 58 trial further support the cardiovascular effects of Farxiga in type-2 diabetes
-
US FDA grants saracatinib Orphan Drug Designation for idiopathic pulmonary fibrosis
-
AstraZeneca showcases next-generation Oncology pipeline addressing unmet patient needs at AACR Annual Meeting
-
AstraZeneca to present new cardiovascular data on Farxiga in type-2 diabetes at ACC 2019
-
Lynparza receives positive EU CHMP opinion for use in germline BRCA-mutated HER2-negative advanced breast cancer
-
Lynparza significantly delayed disease progression as 1st-line maintenance treatment in germline BRCA-mutated metastatic pancreatic cancer
-
Brilinta’s Phase III THEMIS trial met primary endpoint in patients with established coronary artery disease and type-2 diabetes
-
Full-Year 2018 Results
Latest articles and press releases
All of our latest press releases and articles are available to explore
